"Fluorescent Antibody Technique" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy.
| Descriptor ID |
D005455
|
| MeSH Number(s) |
E01.370.225.500.607.512.240 E01.370.225.750.551.512.240 E05.200.500.607.512.240 E05.200.750.551.512.240 E05.478.583.375
|
| Concept/Terms |
Fluorescent Antibody Technique- Fluorescent Antibody Technique
- Antibody Technique, Fluorescent
- Antibody Techniques, Fluorescent
- Fluorescent Antibody Techniques
- Technique, Fluorescent Antibody
- Techniques, Fluorescent Antibody
- Fluorescent Antinuclear Antibody Test
- Immunofluorescence Technic
- Immunofluorescence Technics
- Technic, Immunofluorescence
- Technics, Immunofluorescence
- Immunofluorescence Technique
- Immunofluorescence Techniques
- Technique, Immunofluorescence
- Techniques, Immunofluorescence
- Fluorescent Antibody Technic
- Antibody Technic, Fluorescent
- Antibody Technics, Fluorescent
- Fluorescent Antibody Technics
- Technic, Fluorescent Antibody
- Technics, Fluorescent Antibody
- Coon's Technic
- Coon Technic
- Coons Technic
- Technic, Coon's
- Antinuclear Antibody Test, Fluorescent
- Coon's Technique
- Coon Technique
- Coons Technique
- Technique, Coon's
Fluorescent Protein Tracing- Fluorescent Protein Tracing
- Fluorescent Protein Tracings
- Protein Tracing, Fluorescent
- Protein Tracings, Fluorescent
- Tracing, Fluorescent Protein
- Tracings, Fluorescent Protein
|
Below are MeSH descriptors whose meaning is more general than "Fluorescent Antibody Technique".
Below are MeSH descriptors whose meaning is more specific than "Fluorescent Antibody Technique".
This graph shows the total number of publications written about "Fluorescent Antibody Technique" by people in this website by year, and whether "Fluorescent Antibody Technique" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluorescent Antibody Technique" by people in Profiles.
-
Evaluating DNA damage response through immunofluorescence staining of primordial germ cells in Caenorhabditis elegans L1 larva. STAR Protoc. 2021 06 18; 2(2):100441.
-
Filtration based assessment of CTCs and CellSearch? based assessment are both powerful predictors of prognosis for metastatic breast cancer patients. BMC Cancer. 2018 02 20; 18(1):204.
-
Post-weaning epiphysiolysis causes distal femur dysplasia and foreshortened hindlimbs in fetuin-A-deficient mice. PLoS One. 2017; 12(10):e0187030.
-
Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome. Blood. 2016 Feb 25; 127(8):997-1006.
-
Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features. Nat Genet. 2014 Nov; 46(11):1239-44.
-
The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy. Blood. 2013 Jun 20; 121(25):5078-87.
-
CHD1L: a new candidate gene for congenital anomalies of the kidneys and urinary tract (CAKUT). Nephrol Dial Transplant. 2012 Jun; 27(6):2355-64.
-
Genetic modulation of horizontal cell number in the mouse retina. Proc Natl Acad Sci U S A. 2011 Jun 07; 108(23):9697-702.
-
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Breast Cancer Res Treat. 2010 Nov; 124(2):403-12.
-
Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin Cancer Res. 2010 May 01; 16(9):2634-45.
MeSH information
